Fortis to Introduce India's First Upright Proton Therapy System

Fortis Memorial Research Institute (FMRI) in Gurugram is poised to revolutionize cancer treatment in India by installing the country's first upright proton therapy system. This innovative approach promises to enhance precision in targeting tumors while minimizing damage to surrounding healthy tissues.

Introducing a New Era in Cancer Treatment

The upright proton therapy system, known as the Mevion S250-FIT Proton Therapy System, is developed by Mevion Medical Systems. It incorporates the Marie upright patient positioning and imaging solution from Leo Cancer Care, along with RayStation treatment planning software by RaySearch Laboratories. This will be the first such system to be installed in India, marking a significant advancement in the nation's healthcare capabilities.

Proton therapy is distinct from traditional radiation therapy, which uses X-rays that emit radiation as they pass through the body. In contrast, proton therapy delivers the prescribed dose directly to the tumor, significantly reducing radiation exposure to adjacent healthy tissues and vital organs. This precision is particularly beneficial for treating pediatric cancers and tumors near critical structures like the brain and spinal cord.

Technological Advancements and Patient Benefits

The system combines an ultra-compact proton accelerator with a fixed-beam delivery architecture and a 360-degree upright patient-positioning platform. It also integrates CT imaging for enhanced accuracy. Unlike conventional systems that rotate a large treatment gantry around a patient lying on a table, this technology positions the patient in a seated stance in front of a fixed proton beam.

Fortis officials highlight that this method allows for more precise targeting of cancerous cells, minimizing the risk of damage to non-cancerous areas. The installation of the system is subject to regulatory approvals and necessary site preparations, which are currently underway.

Potential Impact on Indian Healthcare

This development is expected to significantly impact cancer care in India, offering a new level of treatment precision that aligns with global standards. The introduction of such advanced technology underscores Fortis's commitment to leading the way in healthcare innovations.

By adopting the upright proton therapy system, Fortis aims to provide patients with access to the latest in cancer treatment technology, potentially improving outcomes and reducing side effects associated with traditional radiation therapies. As healthcare providers in India continue to adopt such innovations, the overall quality of cancer care in the country is likely to improve, offering new hope to patients nationwide.

With this installation, Fortis Memorial Research Institute sets a new benchmark in the Indian healthcare sector, signaling a shift towards more advanced and patient-friendly cancer treatment options.